Investors

Date	Name	Title	Type	Shares Traded	Price Range
Mar 31, 2011	brown michael s	Director	Automatic Sell	3,309	44.65
Jan 18, 2011	brown michael s	Director	Automatic Sell	4,845	34.88
Jan 19, 2011	brown michael s	Director	Automatic Sell	5,155	35.59 - 35.60
Mar 9, 2011	brown michael s	Director	Automatic Sell	6,906	39.35 - 40.00
Mar 10, 2011	brown michael s	Director	Automatic Sell	3,094	39.09
Oct 6, 2010	brown michael s	Director	Automatic Sell	3,235	29.05
Oct 7, 2010	brown michael s	Director	Automatic Sell	1,765	28.03
Dec 20, 2010	brown michael s	Director	Automatic Sell	2,103	32.89 - 33.24
Dec 17, 2010	brown michael s	Director	Automatic Sell	2,897	32.44
Jan 17, 2008	brown michael s	Director	Automatic Sell	200	25.00
Jan 22, 2008	brown michael s	Director	Automatic Sell	9,800	25.00
Nov 6, 2007	brown michael s	Director	Automatic Sell	6,108	19.42 - 20.08
Nov 5, 2007	brown michael s	Director	Automatic Sell	13,292	20.31 - 20.66
Nov 5, 2007	brown michael s	Director	Automatic Sell	600	20.67 - 20.87
Mar 1, 2012	brown michael s	Director	Automatic Sell	20,000	102.65 - 104.32
Sep 21, 2011	brown michael s	Director	Automatic Sell	5,000	78.00
Sep 7, 2011	brown michael s	Director	Automatic Sell	5,000	69.00
Sep 8, 2011	brown michael s	Director	Automatic Sell	5,000	74.00
Mar 21, 2013	brown michael s	Director	Automatic Sell	15,000	172.61 - 174.13
Mar 17, 2011	gilman alfred g	Director	Automatic Sell	18,347	38.92
Showing 381-400 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.